Dr. Yael Richter, has a PhD in medicinal chemistry from Bar-Ilan University. She serves as the VP R&D at VAYA pharma, which is the pharmaceutical division of Enzymotec, an international biotech company. In her role, Dr. Richter oversees the pre-clinical and clinical research, regulation, and intellectual property affairs. Dr. Richter has years of experience in clinical development, as well as a strong background in regulatory affairs. Her main field of interest is the potential role of lipids in the management of CNS disorders, mainly early memory impairment and ADHD.